BRPI0306851A2 - aplicação de derivados de polissacarídeos como substâncias antiinfectantes - Google Patents

aplicação de derivados de polissacarídeos como substâncias antiinfectantes

Info

Publication number
BRPI0306851A2
BRPI0306851A2 BRPI0306851A BR0306851A BRPI0306851A2 BR PI0306851 A2 BRPI0306851 A2 BR PI0306851A2 BR PI0306851 A BRPI0306851 A BR PI0306851A BR 0306851 A BR0306851 A BR 0306851A BR PI0306851 A2 BRPI0306851 A2 BR PI0306851A2
Authority
BR
Brazil
Prior art keywords
sub
group
alpha
alkyl
polysaccharide derivative
Prior art date
Application number
BRPI0306851A
Other languages
English (en)
Other versions
BRPI0306851A8 (pt
Inventor
Albert Härtl
Hans-Martin Dahse
Michaela Schmidtke
Thomas Heinze
Ute Mollmann
Vera Haack
Original Assignee
Woff Cellulosics Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Woff Cellulosics Gmbh & Co Kg filed Critical Woff Cellulosics Gmbh & Co Kg
Publication of BRPI0306851A2 publication Critical patent/BRPI0306851A2/pt
Publication of BRPI0306851A8 publication Critical patent/BRPI0306851A8/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • A61K31/717Celluloses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • A61K31/718Starch or degraded starch, e.g. amylose, amylopectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • A61K31/719Pullulans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • A61K31/721Dextrans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
BRPI0306851A 2002-01-10 2003-01-10 Aplicação de derivados de polissacarídeos como substâncias antiinfectantes BRPI0306851A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10200717A DE10200717A1 (de) 2002-01-10 2002-01-10 Verwendung von Polysaccharid-Derivaten als antiinfektive Substanzen
PCT/DE2003/000095 WO2003057227A1 (de) 2002-01-10 2003-01-10 Verwendung von polysaccharid-derivaten als antiinfektive substanzen

Publications (2)

Publication Number Publication Date
BRPI0306851A2 true BRPI0306851A2 (pt) 2016-11-16
BRPI0306851A8 BRPI0306851A8 (pt) 2017-04-25

Family

ID=7711838

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0306851A BRPI0306851A8 (pt) 2002-01-10 2003-01-10 Aplicação de derivados de polissacarídeos como substâncias antiinfectantes

Country Status (17)

Country Link
US (1) US7297687B2 (pt)
EP (1) EP1465640B8 (pt)
JP (1) JP4452777B2 (pt)
KR (1) KR100913301B1 (pt)
CN (1) CN1615141B (pt)
AT (1) ATE408411T1 (pt)
AU (1) AU2003210125B2 (pt)
BR (1) BRPI0306851A8 (pt)
CA (1) CA2472586C (pt)
DE (2) DE10200717A1 (pt)
ES (1) ES2314205T3 (pt)
MX (1) MXPA04006673A (pt)
NO (1) NO20043265L (pt)
PL (1) PL206600B1 (pt)
RU (1) RU2332221C2 (pt)
WO (1) WO2003057227A1 (pt)
ZA (1) ZA200405400B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1635661T1 (sl) * 2003-06-13 2011-01-31 Torkel Wadstrom Proizvod za absorpcijske namene
CN100469707C (zh) * 2005-03-11 2009-03-18 中国石化北京燕化石油化工股份有限公司 一种高浊高铁循环冷却水的处理方法
KR101278106B1 (ko) * 2011-03-03 2013-06-24 이원실 이온성 액체를 이용한 셀룰로오스계 고분자 항균제의 제조방법
WO2013132061A1 (de) 2012-03-09 2013-09-12 Friedrich-Schiller-Universität Jena Di- und multifunktional amin-modifizierte oligo- und polysaccharidderivate als antiinfektive substanzen und deren verwendung
EP3227379B1 (en) * 2014-12-02 2020-07-29 B.G. Negev Technologies and Applications Ltd., at Ben-Gurion University Quaternized starches for use as anti-microbial agents
FR3064473B1 (fr) * 2017-04-03 2021-02-12 Basf Beauty Care Solutions France Sas Ingredient protecteur de l'equilibre de la flore microbienne cutanee et/ou mucosale
EP3824896A4 (en) * 2018-07-20 2022-08-24 Shiseido Company, Ltd. VIRUS INACTIVATION AGENT
CN115260320B (zh) * 2021-04-30 2023-05-05 中国科学院化学研究所 离子型多糖衍生物用作防冰涂层材料的应用
KR102559540B1 (ko) 2022-09-19 2023-07-25 문건희 토류벽시스템용 토류벽체

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60203265A (ja) * 1984-03-28 1985-10-14 ダイセル化学工業株式会社 抗血液凝固性高分子材料
DE3711680A1 (de) 1987-04-07 1988-10-27 Hoechst Ag Waessrige biozide kationische kunststoffdispersionen und deren verwendung als fungizide, bakterizide und algizide ausruestungsmittel
DE3720555A1 (de) * 1987-06-22 1989-01-05 Henkel Kgaa Verwendung von unloeslichen, polyfunktionellen quartaeren ammoniumverbindungen zur adsorptiven bindung von mikroorganismen
IT1231168B (it) * 1989-07-21 1991-11-22 Texcontor Ets Copolimeri saccaridici aventi attivita' antibatterica.
JPH0457969A (ja) * 1990-06-27 1992-02-25 Unitika Ltd 抗菌性布帛の製造方法
US5731259A (en) 1991-05-03 1998-03-24 Societa Consortile Ricerche Angelini S.P.A. Cationic polysaccharides
IT1249309B (it) * 1991-05-03 1995-02-22 Faricerca Spa Polisaccaridi di tipo cationico
GB2262531B (en) * 1991-12-17 1995-12-06 Erba Carlo Spa Antiviral sulphated polysaccharides
JPH05295002A (ja) * 1992-04-23 1993-11-09 Nichiden Kagaku Kk 抗菌性澱粉、水溶性多糖類及びその製造方法
ZA947572B (en) 1993-09-29 1995-09-28 Hampton Roads Medical College Contraceptive compositions
JPH10155898A (ja) * 1996-11-26 1998-06-16 Toyobo Co Ltd 抗菌性付与抗血栓性材料
US6096291A (en) 1996-12-27 2000-08-01 Biovector Therapeutics, S.A. Mucosal administration of substances to mammals
US6306835B1 (en) * 1997-09-23 2001-10-23 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Biocidal chitosan derivatives
CN1203833C (zh) * 1998-04-09 2005-06-01 国家淀粉及化学投资控股公司 美发组合物
AU6473499A (en) * 1998-10-29 2000-05-22 Ciba Specialty Chemicals Holding Inc. Incorporation of organic anti-microbials into fibres during a fibre spinning process

Also Published As

Publication number Publication date
EP1465640B1 (de) 2008-09-17
MXPA04006673A (es) 2004-11-10
DE10200717A1 (de) 2003-07-31
EP1465640B8 (de) 2009-04-01
JP2005519057A (ja) 2005-06-30
WO2003057227A1 (de) 2003-07-17
CA2472586A1 (en) 2003-07-17
RU2004124389A (ru) 2005-05-10
PL370887A1 (en) 2005-05-30
DE50310510D1 (de) 2008-10-30
BRPI0306851A8 (pt) 2017-04-25
US7297687B2 (en) 2007-11-20
NO20043265L (no) 2004-08-04
US20050054609A1 (en) 2005-03-10
KR100913301B1 (ko) 2009-08-26
ZA200405400B (en) 2005-11-30
KR20040079415A (ko) 2004-09-14
ES2314205T3 (es) 2009-03-16
AU2003210125A1 (en) 2003-07-24
RU2332221C2 (ru) 2008-08-27
CN1615141A (zh) 2005-05-11
JP4452777B2 (ja) 2010-04-21
AU2003210125B2 (en) 2008-01-24
PL206600B1 (pl) 2010-08-31
CA2472586C (en) 2011-03-15
CN1615141B (zh) 2013-08-14
ATE408411T1 (de) 2008-10-15
EP1465640A1 (de) 2004-10-13

Similar Documents

Publication Publication Date Title
BR0316375A (pt) Diazinopirimidinas
HK1081199A1 (en) Process and intermediates for the preparation of (1r,2s,5s)-6,6-dimethyl-3- azabicyclo [3,1,0] hexane-2-carboxylates or salts thereof
BG108318A (en) Carboxamide-substituted phenylurea derivatives and method for the production and use thereof as medicaments
BRPI0507984A (pt) composto ou um sal do mesmo, processo para produzir um composto, medicamento, métodos para antagonizar angiotensina ii em um mamìfero, para melhorar a resistência de insulina em um mamìfero e para prevenir ou tratar doenças circulatórias em um mamìfero, e, uso do composto
NO20062763L (no) Pyrrolotriazinforbindelser som kinaseinhibitorer
BRPI0412851A (pt) benzamidazóis de n-metila-substituìdos
HK1091481A1 (en) Therapeutic agents useful for treating pain
EA200600621A1 (ru) Производные тетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств
BR0309343A (pt) Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas
MY136686A (en) Salt forms of 3-(4-bromo-2,6-difluoro-benzyloxy)-5-[3-(4-pyrrolidin-1-yl-butyl)-ureido]-isothiazole-4-carboxylic acid amide and method of production
WO2005030766A8 (en) Phenyl - carboxamide compounds useful for treating pain
IS7067A (is) Imídasólafleiður til að stilla natríumgöng
NO20050270L (no) Nye forbindelser, deres anvendelse og fremstilling
BRPI0306851A8 (pt) Aplicação de derivados de polissacarídeos como substâncias antiinfectantes
ATE238981T1 (de) Antitumorwirkstoffe
MA27232A1 (fr) Derives d'acide n-benzoylureidocinnamique, leurs procedes de preparation et leurs utilisations
SE9903894D0 (sv) Novel compounds
EA200601249A1 (ru) Пиперазины, пригодные для лечения боли
NO20054418L (no) Substituert benzoylureidopyridylpiperidin- og -pyrrolidinkarboksylsyrederivater, deres fremstilling og anvendelse
NO20044881L (no) Acyl-3-karboksyfenylureaderivater, fremstillingsfremgangsmate og anvendelse derav
TW200505869A (en) Thiophenylaminoimidazolines
CY1107483T1 (el) Παραγωγα πυριδαζινης, η χρηση τους ως φαρμακευτικα σκευασματα και η διαδικασια παρασκευης τους
ATE346080T1 (de) Steroid-verbindungen mit anti-tumoraler wirkung
DE60216090D1 (de) Verwendung von l-acetylcarnitin zur herstellung eines medikaments zur behandlung von anhedonia
ATE350034T1 (de) Verwendung von epothilone zur behandlung hyperparathyreoidismus

Legal Events

Date Code Title Description
B06H Technical and formal requirements: requirement cancelled [chapter 6.8 patent gazette]

Free format text: ANULADA A EXIGENCIA CODIGO 6.7 PUBLICADA NA RPI NO 1869 DE 30/10/2006, POR TER SIDO INDEVIDA.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B25D Requested change of name of applicant approved

Owner name: DOW WOLFF CELLULOSICS GMBH AND CO. OHG (DE)

B25G Requested change of headquarter approved

Owner name: DOW WOLFF CELLULOSICS GMBH AND CO. OHG (DE)

B25A Requested transfer of rights approved

Owner name: DOW WOLFF CELLULOSICS GMBH (DE)

B25A Requested transfer of rights approved

Owner name: DOW GLOBAL TECHNOLOGIES INC (US)

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]